Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 2
1978 1
1979 1
1983 2
1984 1
1985 2
1986 5
1987 5
1988 3
1989 3
1991 2
1992 7
1993 4
1994 5
1995 5
1996 2
1997 3
1999 1
2001 2
2002 2
2003 1
2004 7
2005 2
2006 5
2007 3
2008 3
2009 1
2010 1
2011 2
2012 2
2013 1
2014 1
2015 3
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors.
Ab O, Whiteman KR, Bartle LM, Sun X, Singh R, Tavares D, LaBelle A, Payne G, Lutz RJ, Pinkas J, Goldmacher VS, Chittenden T, Lambert JM. Ab O, et al. Among authors: goldmacher vs. Mol Cancer Ther. 2015 Jul;14(7):1605-13. doi: 10.1158/1535-7163.MCT-14-1095. Epub 2015 Apr 22. Mol Cancer Ther. 2015. PMID: 25904506
Cell killing by antibody-drug conjugates.
Kovtun YV, Goldmacher VS. Kovtun YV, et al. Among authors: goldmacher vs. Cancer Lett. 2007 Oct 8;255(2):232-40. doi: 10.1016/j.canlet.2007.04.010. Epub 2007 Jun 5. Cancer Lett. 2007. PMID: 17553616 Review.
Cell death suppressors encoded by cytomegalovirus.
Goldmacher VS. Goldmacher VS. Prog Mol Subcell Biol. 2004;36:1-18. doi: 10.1007/978-3-540-74264-7_1. Prog Mol Subcell Biol. 2004. PMID: 15171604 Review. No abstract available.
Tumor-specific novel taxoid-monoclonal antibody conjugates.
Ojima I, Geng X, Wu X, Qu C, Borella CP, Xie H, Wilhelm SD, Leece BA, Bartle LM, Goldmacher VS, Chari RV. Ojima I, et al. Among authors: goldmacher vs. J Med Chem. 2002 Dec 19;45(26):5620-3. doi: 10.1021/jm025540g. J Med Chem. 2002. PMID: 12477344
Antibody-maytansinoid conjugates designed to bypass multidrug resistance.
Kovtun YV, Audette CA, Mayo MF, Jones GE, Doherty H, Maloney EK, Erickson HK, Sun X, Wilhelm S, Ab O, Lai KC, Widdison WC, Kellogg B, Johnson H, Pinkas J, Lutz RJ, Singh R, Goldmacher VS, Chari RV. Kovtun YV, et al. Among authors: goldmacher vs. Cancer Res. 2010 Mar 15;70(6):2528-37. doi: 10.1158/0008-5472.CAN-09-3546. Epub 2010 Mar 2. Cancer Res. 2010. PMID: 20197459
Formaldehyde is mutagenic for cultured human cells.
Goldmacher VS, Thilly WG. Goldmacher VS, et al. Mutat Res. 1983 Mar;116(3-4):417-22. doi: 10.1016/0165-1218(83)90080-0. Mutat Res. 1983. PMID: 6835255 No abstract available.
91 results